What does the evidence say about Ginkgo Reaction Time Meta-Analysis?

The current Migaku evidence database contains 2 reusable source documents for Ginkgo Reaction Time Meta-Analysis. This answer focuses on benefits, uncertainty, and practical interpretation. - A random-effects meta-analysis using the REML estimator was applied to calculate relative risk (RR), including continuity corrections for zero-event studies. [Pena E (2026); evidence level 1] - Data extraction was performed in duplicate, and risk of bias was evaluated using the Cochrane tool. [Pena E (2026); evidence level 1] - Pooled estimates showed a non-significant trend toward reduced AMS incidence with antioxidant treatment (RR ≈ 0.73; 95% CI: 0.47-1.11; p = 0.14). [Pena E (2026); evidence level 1] - Acute Mountain Sickness (AMS) is a frequent condition triggered by exposure to hypobaric hypoxia at high altitude. [Pena E (2026); evidence level 1] - Conclusion The NMA results indicate that in terms of learning and memory functions, raisin and tart cherry ranked higher; in terms of executive functions, the bacopa monnieri compound demonstrated a relatively better intervention effect, providing an important basis for non-drug interventions for cognitive health in the healthy older adults. [Feng X (2026); evidence level 1] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.